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Abstract 
We report a case of simultaneous bilateral nonarteritic anterior ischemic optic 
neuropathy (NAION) due to sildenafil use. A 55-year-old man with an unremarkable 
medical history presented simultaneous bilateral NAION 8 months after continuous use 
of sildenafil 4–5 times a month. At presentation, visual acuity (VA) was 0.7 in the right 
eye (RE) and 0.9 in the left eye (LE). The visual field showed an inferior altitudinal defect 
in both eyes and a fundus examination revealed prominent optic disc edema in the RE 
and a crowded optic disc in the LE. The patient was counseled to discontinue sildenafil, 
and 3 weeks later VA was 1.0 in both eyes and the optic disc edema in the RE was 
resolved. However, a visual field defect remained in the RE. Three months later, visual 
fields were unchanged. To the best of our knowledge, this is the first reported case of 
simultaneous bilateral NAION due to sildenafil use. 
 
Introduction 
Sildenafil citrate (Viagra) is a potent and selective cyclic guanosine monophosphate 
(cGMP)-specific phosphodiesterase type 5 (PDE5) inhibitor. Increased cGMP results in 
relaxation and vasodilation of vascular smooth muscle [1, 2] and enhances penile erectile 
function in men. Some reports suggest that sildenafil use may be associated with 
nonarteritic anterior ischemic optic neuropathy (NAION) [3, 4], and several patients have 
developed NAION between 1 and 12 h after taking sildenafil [5]. We report, for the first 
time, to our knowledge, a case of bilateral simultaneous anterior NAION after taking 
sildenafil. Case Rep Ophthalmol 2011;2:262–265 
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Case Report 
A 55-year-old man with an unremarkable medical history had noticed vision troubles in both eyes, 
associated with nausea and headache. Over the previous 8 months, he had taken 50 mg of sildenafil 4–5 
times a month. At presentation, visual acuity (VA) was 0.7 in the right eye (RE) and 0.9 in the left eye 
(LE), with a right-sided relative afferent pupillary defect. The patient was able to read Ishihara plates 
with each eye separately and without any errors; testing with a Humphrey Visual Field Analyzer 
confirmed an inferior altitudinal defect in both the RE and LE. Fundus examination revealed prominent 
optic disc edema with some rim disc hemorrhages in the RE. In the LE, the optic disc was crowded with 
a blurred optic disc margin and distended retinal veins. Blood pressure and pulse measured 130/60 mm 
Hg and 90 beats per minute, respectively. Laboratory testing revealed a normal antinuclear antibody 
titer, an erythrocyte sedimentation rate of 10 mm/h, a normal complete blood count, and a normal 
tuberculosis skin test. Also, an MRI of the brain with gadolinium and fat suppression demonstrated 
nothing abnormal. The absence of any evidence of a systemic inflammatory disease led us to conclude 
that the patient had experienced bilateral NAION mainly in the RE. The patient was counseled to 
discontinue sildenafil without any other treatment. Three weeks later, VA was 1.0 in both eyes; the 
visual field in the LE was normal, but the visual field defect in the RE remained. Optic disc edema in the 
RE was resolved. Three months after presentation, visual fields were unchanged (fig. 1). 
Discussion 
Since 2001, sporadic cases of NAION due to sildenafil use have been reported [3–5]. In 
all these cases, the affection was unilateral and most had a small, crowded optic nerve 
head (‘disc at risk’). Only 2 cases of bilateral NAION have been reported to date. 
However, in the first of these cases, the patient had experienced a previous episode in the 
fellow eye several months before starting treatment with sildenafil [3]. According to the 
authors, the patient had bilateral disc-at-risk appearance. In the second case, the patient 
experienced bilateral posterior NAION after a megadose of sildenafil; he also had a 
history of systemic hypertension, lipidemia and stroke [6]. To the best of our knowledge, 
ours is the first reported case of bilateral simultaneous NAION in a patient without prior 
medical history or other ischemic stigmata. We suggest, like others [7], that the disc-at-
risk configuration predisposes patients to NAION, and it is reasonable to advise these 
patients to be cautious about using sildenafil or any other medication that might cause 
systematic hypotension. 
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Fig. 1. a Appearance of both optic discs at presentation and 3 months afterward. b Visual field defects 
at presentation and 3 months afterward. 
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